ChemicalBook >> CAS DataBase List >>2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1)
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1)
- CAS No.
- 1369427-40-6
- Chemical Name:
- 2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1)
- Synonyms
- Boc-Dap-OH.DCHA;N-Boc-dolaproine (dicyclohexylamine);N-Boc-Dolaproline DCHA;N-Boc-(2R,3R,4S)-dolaproine DCHA salt;(2R,3R)-BOC-dolaproine dicyclohexylamine;Dicyclohexylamine (2R,3R)-3-[(S)-1-Boc-2-pyrrolidinyl]-3-methoxy-2-methylpropanoate;(2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid.DHEA;dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate;(2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid N-cyclohexylcyclohexanamine salt;(2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid N-cyclohexylcyclohexanamine salt(1:1)
- CBNumber:
- CB63367339
- Molecular Formula:
- C26H48N2O5
- Molecular Weight:
- 468.68
- MDL Number:
- MFCD31560448
- MOL File:
- 1369427-40-6.mol
- MSDS File:
- SDS
Last updated:2025-07-16 09:55:25
| Product description | Number | Pack Size | Price |
| Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | UEC42740 | 0.25g | $900 |
| Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | UEC42740 | 0.1g | $900 |
| Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | UEC42740 | 0.05g | $900 |
| Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | UEC42740 | 0.025g | $900 |
| Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | UEC42740 | 0.01g | $900 |
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1) Properties
| storage temp. | 2-8°C, stored under nitrogen, away from moisture |
|---|---|
| form | Solid |
| color | White to off-white |
| InChIKey | PKZALTWOMMNNOL-QNEVMNBPNA-N |
| SMILES | N(C1CCCCC1)C1CCCCC1.[C@@H]([C@]1([H])CCCN1C(=O)OC(C)(C)C)(OC)[C@@H](C)C(=O)O |&1:13,14,29,r| |
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1) price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | UEC42740 | Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | 1369427-40-6 | 0.25g | $900 | 2026-06-05 | Buy |
| Biosynth | UEC42740 | Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | 1369427-40-6 | 0.1g | $900 | 2026-06-05 | Buy |
| Biosynth | UEC42740 | Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | 1369427-40-6 | 0.05g | $900 | 2026-06-05 | Buy |
| Biosynth | UEC42740 | Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | 1369427-40-6 | 0.025g | $900 | 2026-06-05 | Buy |
| Biosynth | UEC42740 | Dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate | 1369427-40-6 | 0.01g | $900 | 2026-06-05 | Buy |
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1) Chemical Properties,Uses,Production
Uses
N-Boc-dolaproine dicyclohexylamine is an amino acid residue of the pentapeptide Dolastatin 10 (HY-15580). Dolastatin 10 inhibits tubulin polymerization and mitosis and has anticancer activity. And contains dicyclohexylamine[1].
References
[1] Almeida W P, et al. An easy and stereoselective synthesis of N-Boc-dolaproine via the Baylis–Hillman reaction[J]. Tetrahedron letters, 2003, 44(5): 937-940.
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1) Preparation Products And Raw materials
Raw materials
Preparation Products
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1) Suppliers
Global( 49)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32998 | 60 |
| Jinan Carbotang Biotech Co.,Ltd. | +8615866703830 | figo.gao@foxmail.com | China | 8491 | 58 |
| Career Henan Chemica Co | +86-0371-86658258 +86-13203830695 | laboratory@coreychem.com | China | 30203 | 58 |
| Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 | sales@huarongpharm.com | CHINA | 3147 | 58 |
| Nextpeptide Inc | +86-0571-81612335 +8613336028439 | sales@nextpeptide.com | China | 19905 | 58 |
| Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +86-15965530500 | nickzhang@hangyubiotech.com | China | 9935 | 58 |
| Beijing Toachem Chemical Co.,Ltd | +86-18612533579 | sales@toachem.com | China | 205 | 58 |
| NANJING YINGWEN BIOTECHNOLOGY CO LTD | +86-13382787392 | sales@aeechem.com | China | 10002 | 58 |
| Nanjing Moldeep Biochemical Co., Ltd. | +86-25-58282389 +86-17351037455 | inquiries@moldeep.com | China | 19999 | 58 |
| Chemyouth Life Science(Suzhou)Co.,Ltd | 18605123100 | kaiyuezhang@chemyouth.com | China | 144 | 58 |
1369427-40-6(2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1))Related Search:
Dicyclohexylamine (2S,3S)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate
Dicyclohexylamine (2S,3S)-3-((R)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate
Dicyclohexylamine (2R,3S)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1)
BOC-HYP-OH DCHA
1of2
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1)
(2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid.DHEA
dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate
(2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid N-cyclohexylcyclohexanamine salt
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-b-methoxy-a-methyl-, (aR,bR,2S)-, compd. with N-cyclohexylcyclohexanamine
(2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid N-cyclohexylcyclohexanamine salt(1:1)
2-?Pyrrolidinepropanoic acid, 1-?[(1,?1-?dimethylethoxy)?carbonyl]?-?β-?methoxy-?α-?methyl-?, (αR,?βR,?2S)?-?, compd. with N-?cyclohexylcyclohexan?amine
N-cyclohexylcyclohexanamine (2R,3R)-3-methoxy-2-methyl-3-[(2S)-1-[(2-methylpropan-2-YL)oxycarbonyl]pyrrolidin-2-YL]propanoic acid
2-PYRROLIDINEPROPANOIC ACID, 1-[(1,1-DIMETHYLETHOXY)CARBONYL]-BETA-METHOXY-ALPHA-METHYL-, (ALPHAR,BETAR,2S)-, COMPD WITH N-CYCLOHEXYLCYCLOHEXANAMINE (1:1)
N-Boc-(2R,3R,4S)-dolaproine DCHA salt
N-Boc-Dolaproline DCHA
Dicyclohexylamine (2R,3R)-3-[(S)-1-Boc-2-pyrrolidinyl]-3-methoxy-2-methylpropanoate
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1)
(2R,3R)-BOC-dolaproine dicyclohexylamine
Boc-Dap-OH.DCHA
N-Boc-dolaproine (dicyclohexylamine)
1369427-40-6
C12H23NC14H25NO5
ADC
ADCs




